Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
about
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusionIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentHepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-AnalysisThe Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-AnalysisTransfusion transmission of HCV, a long but successful road map to safetyRisk factors for retrovirus and hepatitis virus infections in accepted blood donors.Hepatitis C.Transfusion-Transmitted InfectionsTransfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.Blood banking and transfusion medicine for the nephrologist.Blood banking and transfusion medicine for the apheresis medicine practitioner.Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.Low compliance of men having sex with men with self-deferral from blood donation in a Chinese populationAssociation of Toll-like receptor polymorphisms with HIV status in North AmericansTransfusion transmitted infections in solid organ transplantation.Attitudes of North Carolina law enforcement officers toward syringe decriminalization.Knowledge of HIV testing and attitudes towards blood donation at three blood centres in Brazil.Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donorsImpact of HIV Infection on Medicare Beneficiaries with Lung Cancer.Adverse effects of plasma transfusionExtensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries.Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.Cost implications of implementation of pathogen-inactivated plateletsModelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy.Molecular virology in transfusion medicine laboratory.Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil.Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit.Chronic hepatitis C virus (HCV) disease burden and cost in the United States.Comment on: One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.Sensitization from transfusion in patients awaiting primary kidney transplant.Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis.Host genetic basis for hepatitis C virus clearance: a role for blood collection centersEvolving epidemiology of hepatitis C virus in the United States.Recent advances toward defining the benefits and risks of erythrocyte transfusions in neonates.Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.Blood safety and availability: continuing challenges in China's blood banking system.Novel therapies for hepatitis C - one pill fits all?Current testing strategies for hepatitis C virus infection in blood donors and the way forwardTwo cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testing.
P2860
Q24200170-6862DBEA-B093-4BC7-95AD-B1EB66B37BE2Q26748355-962C8284-021D-4400-953A-C87D173B2FE3Q26768490-A219A9EE-0DA2-4B83-89B1-AB26922BC8C2Q26795711-E204F5E8-7FAD-46CD-A570-2D1C0DBA06F8Q26865471-178D05CD-D850-446A-B817-C0A3F2FA1979Q27346471-5BB106A1-58DF-4E69-92CA-4D04E515F2C8Q28084654-0E9D2643-01F7-4226-89A9-81390AFDE97AQ29571219-62B5ACAB-23C9-46D1-960A-31339F9713E5Q30243882-C2375F06-1D67-44E5-8333-CE15C3314A29Q30454995-B92BE642-720B-4030-94DA-18E01CC9C8F5Q30455410-EE710894-3C31-464F-BD63-B4B4FC79CC82Q33455459-D6BB7F3F-64E0-4D4D-962F-510F1C8AA7D4Q33690833-54C33512-9102-446A-A79F-1163BD264E05Q34642208-2D5ABA5D-387D-4E3B-A283-D3F5D387025CQ34667631-2413AC54-B4E4-454C-96CC-1E1D2D6E75FDQ35595876-3C759AFA-4188-4472-B7DB-8422175735DAQ35683972-F6CB9BA2-6B1D-4E8A-B026-907EC759639CQ35765985-77AAFDBD-2068-4258-8D17-84F348A4EFCBQ35882789-EAA51DCE-B604-405C-92D9-0D2A24A535B1Q35972184-6478750F-B52E-408B-A86C-D18427C9B82FQ36117011-EA853433-046E-47E3-A59A-1B42E818CB39Q36403550-21246924-A46C-4783-898B-ACA5A7A1CCB6Q36404706-3E05738A-BA99-4E5C-8CD9-C8CA8E4FDC1AQ36527644-431B1F8E-BD86-405E-BD73-B693F54A3924Q36766449-6C9AED3F-9A86-46D0-99C7-490210303DD6Q37004488-99618EA5-E855-4D47-9445-2598343C7B5CQ37070161-2AAED4BE-1093-40C7-86EE-530860735407Q37148328-91034BC9-0DFA-41E3-BDC9-9C129C4D3740Q37212572-D9ED2F77-28FB-467B-93FA-F16A7772A2A3Q37262842-DDA12097-56FD-48D2-BBEE-E1D4F1202C5CQ37333851-1EA8C042-901D-4026-A445-84CDB933EEB3Q37413784-4B222AB2-F804-4AD3-B3E8-464F41023CEFQ37781667-F8D23E03-858C-43FF-93AD-EC8E2D0806B0Q38020157-C1BEA974-DF42-4F80-901F-6BD4EDDC4F11Q38023134-1D483375-D8FC-46A1-88BA-2422C9314F65Q38030586-B80012EE-8273-4CBD-9186-44551A56BFB6Q38109645-18CE9F48-DB9D-4418-A19E-0B5A2215088CQ38117549-A331AE53-55FD-41AC-89D8-0432B3A04110Q38198619-73D75089-F0CA-4387-80E4-44E86CC8B605Q38403039-DA7F5186-7CAA-408C-94AA-D50AC69FD7D2
P2860
Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@en
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@nl
type
label
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@en
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@nl
prefLabel
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@en
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@nl
P2093
P1433
P1476
Prevalence, incidence, and res ...... ction of nucleic acid testing.
@en
P2093
David E Krysztof
Edward P Notari
Fatemeh Musavi
Gregory A Foster
Kerri A Dorsey
Roger Y Dodd
Shimian Zou
P2860
P304
P356
10.1111/J.1537-2995.2010.02622.X
P577
2010-03-12T00:00:00Z